The physiological function of the agouti-related peptide gene: the control of weight and metabolic rate

References

• Thornton JE, Cheung CC, Clifton DK, Steiner RA.Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice.Endocrinology 1997; 138: 5063–6.
   PubMed Web of Science ®Google Scholar
• Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, et al. Leptin increases hypothalamic proopiomelanocortin mRNA expression in the rostral arcuate nucleus.Diabetes 1997; 46: 2119–23.
   PubMed Web of Science ®Google Scholar
• Mizuno TM, Kleopoulos SP, Bergen HT, Roberts JL, Priest CA, Mobbs CV. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and in ob/ob and db/db mice, but is stimulated by leptin.Diabetes 1998; 47: 294–7.
   PubMed Web of Science ®Google Scholar
• Kim EM, O'Hare E, Grace MK, Welch CC, Billington CJ, Levine AS. ARC POMC mRNA and PVN alpha-MSH are lower in obese relative to lean zucker rats.Brain Res 2000; 862: 11–6.
   PubMed Web of Science ®Google Scholar
• Guan XM, Yu H, Van der Ploeg LH. Evidence of altered hypothalamic pro-opiomelanocortin/ neuropeptide Y mRNA expression in tubby mice.Brain Res Mol Brain Res 1998; 59: 273–9.
   PubMedGoogle Scholar
• Poggioli R, Vergoni AV, Bertolini A. ACTH-(l-24) and alpha-MSH antagonize feeding behavior stimulated by kappa opiate agonists.Peptides 1986; 7: 843–8.
   PubMedGoogle Scholar
• Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.Nature 1997; 385: 165–8.
   PubMed Web of Science ®Google Scholar
• Thiele TE, van Dijk G, Yagaloff KA, Fisher SL, Schwartz M, Burn P, et al. Central infusion of melanocortin agonist MTII in rats: assessment of c- Fos expression and taste aversion.Am J Physiol 1998; 274: R248–54.
   Google Scholar
• Cowley MA, Pronchuk N, Fan W, Dinulescu DM, Colmers WF, Cone RD. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat.Neuron 1999; 24: 155–63.
   PubMed Web of Science ®Google Scholar
• Hohmann JG, Teal TH, Clifton DK, Davis J, Hruby VJ, Han G, et al. Differential role of melanocortins in mediating leptin's central effects on feeding and reproduction.Am ] Physiol Regul lntegr Comp Physiol 2000; 278: R50–9.
   Google Scholar
• Pierroz DD, Ziotopoulou M, Ungsunan L, Moschos S, Flier JS, Mantzoros CS. Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity.Diabetes 2002; 51: 1337–45.
   PubMed Web of Science ®Google Scholar
• Raposinho PD, Castillo E, d'AUeves V, Broqua P, Pralong FP, Aubert ML. Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes.Endocrinology 2000; 141: 4419–27.
   Google Scholar
• Adage T, Scheurink AJ, de Boer SF, de Vries K, Konsman JP, Kuipers F, et al. Hypothalamic, metabolic, and behavioral responses to pharmacological inhibition of CNS melanocortin signaling in rats.] Nenrosci 2001; 21: 3639–45.
   Google Scholar
• Bultman SJ, Michaud EJ, Woychik RP. Molecular characterization of the mouse agouti locus.Cell 1992; 71: 1195–204.
   PubMed Web of Science ®Google Scholar
• Yen TT, Gill AM, Frigeri LG, Barsh GS, Wolff GL. Obesity, diabetes, and neoplasia in yellow A(vy)/- mice: ectopic expression of the agouti gene.FASEB ] 1994; 8: 479–88.
   PubMed Web of Science ®Google Scholar
• Miller MW, Duhl DM, Vrieling H, Cordes SP, Ollmann MM, Winkes BM, et al. Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation.Genes Dev 1993; 7: 454� 67.
   Google Scholar
• Mountjoy KG, Robbins LS, Mortrud MT, Cone RD. The cloning of a family of genes that encode the melanocortin receptors.Science 1992; 257: 1248–51.
   PubMed Web of Science ®Google Scholar
• Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, et al. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor.Nature 1994; 371: 799–802.
   PubMed Web of Science ®Google Scholar
• Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain.Mol Endocrinol 1994; 8: 1298–308.
   PubMed Web of Science ®Google Scholar
• Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice.Cell 1997; 88: 131–41.
   PubMed Web of Science ®Google Scholar
• Krude H, Biebermann H, Luck W, Horn R, Brabant G. Gruters. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans.Nat Genet 1998; 19: 155–7.
   PubMed Web of Science ®Google Scholar
• Jackson RS, Creemers JW, Ohagi S, Raffin-Sanson ML, Sanders L, Montague CT, et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase I gene.Nat Genet 1997; 16: 303–6.
   PubMedGoogle Scholar
• Yeo GS, Farooqi IS, Aminian S, Halsall DJ, Stanhope RG, O'Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity.Nat Genet 1998; 20: 111–2.
   PubMed Web of Science ®Google Scholar
• Vaisse C, Clement K, Guy-Grand B, Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity.Nat Genet 1998; 20: 113–4.
   PubMed Web of Science ®Google Scholar
• Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein.Science 1997; 278: 135–8.
   PubMed Web of Science ®Google Scholar
• Shutter JR, Graham M, Kinsey AC, Scully S, Luthy R, Stark KL. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice.Genes Dev 1997; II: 593–602.
   Google Scholar
• Fong TM, Mao C, MacNeil T, Kalyani R, Smith T, Weinberg D, et al. ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors.Biochem Biophys Res Commun 1997; 237: 629–31.
   PubMed Web of Science ®Google Scholar
• Mizuno TM, Mobbs CV. Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting.Endocrinology 1999; 140: 814–7.
   PubMed Web of Science ®Google Scholar
• Graham M, Shutter JR, Sarmiento U, Sarosi I, Stark KL. Overexpression of Agrt leads to obesity in transgenic mice.Nat Genet 1997; 17: 273–4.
   PubMed Web of Science ®Google Scholar
• Hahn TM, Breininger JF, Baskin DG, Schwartz MW. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons.Nat Nenrosci 1998; I: 271–2.
   Google Scholar
• Broberger C, Johansen J, Johansson C, Schalling M, Hokfelt T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monoso-dium glutamate-treated mice.Proc Natl Acad Sci USA 1998; 95: 15043–8.
   PubMed Web of Science ®Google Scholar
• Elias CF, Saper CB, Maratos-Flier E, Tritos NA, Lee C, Kelly J, et al. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. /Comp Neurol 1998; 402: 442–59.
   Google Scholar
• Haskell-Luevano C, Chen P, Li C, Chang K, Smith MS, Cameron JL, et al. Characterization of the neuroanatomical distribution of agouti-related protein immunoreactivity in the rhesus monkey and the rat.Endocrinology 1999; 140: 1408–15.
   PubMed Web of Science ®Google Scholar
• Seoane LM, Lopez M, Tovar S, Casanueva FF, Senaris R, Dieguez C. Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus.Endocrinology 2003; 144: 544–51.
   PubMed Web of Science ®Google Scholar
• Rossi M, Kim MS, Morgan DG, Small CJ, Edwards CM, Sunter D, et al. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo.Endocrinology 1998; 139:4428–31.
   PubMed Web of Science ®Google Scholar
• Hagan MM, Rushing PA, Pritchard LM, Schwartz MW, Strack AM, Van Der Ploeg LH, et al. Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade.Am J Physiol Regul lntegr Comp Physiol 2000; 279: R47–52.
   Google Scholar
• Kim MS, Rossi M, Abbott CR, AlAhmed SH, Smith DM, Bloom SR. Sustained orexigenic effect of Agouti related protein may be not mediated by the melanocortin 4 receptor.Peptides 2002; 23: 1069–76.
   Google Scholar
• Marsh DJ, Miura GI, Yagaloff KA, Schwartz MW, Barsh GS, Palmiter RD. Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues.Brain Res 1999; 848:66-77.
   Google Scholar
• Kim MS, Rossi M, Abusnana S, Sunter D, Morgan DG, Small CJ, et al. Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimu-lating hormone.Diabetes 2000; 49: 177–82.
   PubMed Web of Science ®Google Scholar
• Grill HJ, Ginsberg AB, Seeley RJ, Kaplan JM. Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight.] Nenrosci 1998; 18: 10128–35.
   PubMed Web of Science ®Google Scholar
• Small CJ, Kim MS, Stanley SA, Mitchell JR, Murphy K, Morgan DG, et al. Effects of chronic central nervous system administration of agouti- related protein in pair-fed animals.Diabetes 2001; 50: 248–54.
   PubMedGoogle Scholar
• Asakawa A, Inui A, Goto K, Yuzuriha H, Takimoto Y, Inui T, et al. Effects of agouti-related protein, orexin and melanin-concentrating hormone on oxygen consumption in mice.hit J Mol Med 2002; 10: 523–5.
   Google Scholar
• Frigeri LG, Wolff GL, Teguh C. Differential responses of yellow Avy/A and agouti A/a (BALB/c X VY) Fl hybrid mice to the same diets: glucose tolerance, weight gain, and adipocyte cellularity.hit J Obes 1988; 12: 305–20.
   PubMedGoogle Scholar
• Vink T, Hinney A, van Elburg AA, van Goozen SH, Sandkuijl LA, Sinke RJ, et al. Association between an agouti-related protein gene polymorphism and anorexia nervosa.Mol Psychiatry 2001; 6: 325–8.
   Web of Science ®Google Scholar
• Qian S, Chen H, Weingarth D, Trumbauer ME, Novi DE, Guan X, et al. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice.Mol Cell Biol 2002; 22: 5027–35.
   PubMed Web of Science ®Google Scholar
• Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y.Nature 1996;381:415–21.
   PubMed Web of Science ®Google Scholar
• Erickson JC, Hollopeter G, Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y.Science 1996; 274: 1704–7.
   PubMed Web of Science ®Google Scholar
• Makimura H, Mizuno TM, Mastaitis JW, Agami R, Mobbs CV. Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake. BMCNeurosci 2002; 3: 18.
   Google Scholar
• Mizuno TM, Makimura H, Silverstein J, Roberts JL, Lopingco T, Mobbs CV. Fasting regulates hypothalamic neuropeptide Y, agouti-related peptide, and proopiomelanocortin in diabetic mice independent of changes in leptin or insulin.Endocrinology 1999; 140: 4551–7.
   Google Scholar
• Kim EM, Grace MK, Welch CC, Billington CJ, Levine AS. STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats.Am ] Physiol 1999; 276: R1320–6.
   Google Scholar
• Havel PJ, Hahn TM, Sindelar DK, Sindelar DK, Baskin DG, Dallman MF, et al. Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melano-cortin system and muscle uncoupling protein 3 expression in rats.Diabetes 2000; 49: 244–52.
   Google Scholar
• Qu SY, Yang YK, Li JY, Zeng Q, Gantz I. Agouti-related protein is a mediator of diabetic hyperphagia.Regul Pept 2001; 98: 69–75.
   Google Scholar
• Sindelar DK, Mystkowski P, Marsh DJ, Palmiter RD, Schwartz MW. Attenuation of diabetic hyperphagia in neuropeptide Y-deficient mice.Diabetes 2002; 51: 778–83.
   PubMed Web of Science ®Google Scholar
• Ebihara K, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Satoh N, et al. Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action.Diabetes 1999; 48: 2028–33.
   PubMed Web of Science ®Google Scholar
• Korner J, Savontaus E, Chua SC, Jr, Leibel RL, Wardlaw SL. Leptin regulation of Agrp and Npy mRNA in the rat hypothalamus.J Neuroendocrinal 2001; 13:959-66.
   PubMedGoogle Scholar
• Hagan MM, Benoit SC, Rushing PA, Pritchard LM, Woods SC, Seeley RJ. Immediate and prolonged patterns of Agouti-related peptide-(83–132)-induced c-Fos activation in hypothalamic and extrahypothalamic sites.Endocrinology 2001; 142: 1050–6.
   Google Scholar
• Zheng H, Corkern MM, Crousillac SM, Patterson LM, Phifer CB, Berthoud HR. Neurochemical phenotype of hypothalamic neurons showing Fos expression 23 h after intracranial AgRP.Ant J Physiol Regttl Integr Comp Physiol 2002; 282: R1773–81.
   Google Scholar
• Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus.Nature 2001; 411:480–4.
   PubMed Web of Science ®Google Scholar
• Dhillo WS, Small CJ, Stanley SA, Jethwa PH, Seal LJ, Murphy KG, et al. Hypothalamic interactions between neuropeptide Y, agouti-related protein, cocaine- and amphe- -mine-regulated transcript and alpha-melanocyte-stimulat-ing hormone in vitro in male rats.] Neuroendocrinal 2002; 14: 725–30.
   Web of Science ®Google Scholar
• Hagan MM, Rushing PA, Benoit SC, Woods SC, Seeley RJ. Opioid receptor involvement in the effect of AgRP- (83-132) on food intake and food selection.Am ] Physiol Regul Integr Comp Physiol 2001; 280: R814–21.
   PubMedGoogle Scholar
• Brugman S, Clegg DJ, Woods SC, Seeley RJ. Combined blockade of both micro � and kappa-opioid receptors prevents the acute orexigenic action of Agouti-related protein.Endocrinology 2002; 143: 4265–70.
   PubMed Web of Science ®Google Scholar
• Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach.Nature 1999; 402:656–60
   Google Scholar
• Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.Diabetes 2001; 50: 1714–9.
   PubMed Web of Science ®Google Scholar
• Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats.Diabetes 2001; 50: 2438^3.
   Google Scholar
• Willesen MG, Kristensen P, Romer J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat.Neuroendocrinology 1999; 70: 306–16.
   PubMed Web of Science ®Google Scholar
• Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, et al. A role for ghrelin in the central regulation of feeding.Nature 2001; 409: 194–8.
   PubMed Web of Science ®Google Scholar
• Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression.Endocrinology 2000; 141: 4797–800.
   PubMed Web of Science ®Google Scholar
• Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Yl receptor pathway.Diabetes 2001; 50: 227–32.
   PubMed Web of Science ®Google Scholar
• Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents.Nature 2000; 407: 908–13.
   PubMed Web of Science ®Google Scholar
• Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, Cohen MA, et al. Ghrelin causes hyperphagia and obesity in rats.Diabetes 2001; 50: 2540–7.
   PubMed Web of Science ®Google Scholar
• Pedersen-Bjergaard U, Host U, Kelbaek H, Schifter S, Rehfeld JF, Faber J, et al. Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man.Scand ] Clin Lab Invest 1996; 56: 497–503.
   PubMed Web of Science ®Google Scholar
• Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, et al. Gut hormone PYY(3-36) physiologically inhibits food intake.Nature 2002; 418: 650–4.
   PubMed Web of Science ®Google Scholar
• Sergeyev V, Broberger C, Gorbatyuk O, Hokfelt T. Effect of 2-mercaptoacetate and 2-deoxy-D-glucose administration on the expression of NPY, AGRP, POMC, MCH and hypocre-tin/orexin in the rat hypothalamus.Neuroreport 2000; 11: 117–21.
   PubMed Web of Science ®Google Scholar
• Savontaus E, Conwell IM, Wardlaw SL. Effects of adrenalectomy on AGRP, POMC, NPY and CART gene expression in the basal hypothalamus of fed and fasted rats.Brain Res 2002; 958: 130–8.
   PubMed Web of Science ®Google Scholar
• Makimura H, Mizuno TM, Roberts J, Silverstein J, Beasley J, Mobbs CV. Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice.Diabetes 2000; 49: 1917–23.
   PubMed Web of Science ®Google Scholar
• Lu XY, Shieh KR, Kabbaj M, Barsh GS, Akil H, Watson SJ. Diurnal rhythm of agouti-related protein and its relation to 0. corticosterone and food intake.Endocrinology 2002; 143: 3905–15.
   Google Scholar
• Hisano S, Kagotani Y, Tsuruo Y, Daikoku S, Chihara K, Whitnal MH, et al. Localization of glucocorticoid receptor in neuropeptide Y-containing neurons in the arcuate nucleus of the rat hypothalamus.Neurosci Lett 1988;95: 13–8.
   PubMed Web of Science ®Google Scholar
• Cintra A, Fuxe K, Solfrini V, Agnati LF, Tinner B, Wikstrom AC, et al. Central peptidergic neurons as targets for glucocorticoid action. Evidence for the presence of glucocorticoid receptor immunoreactivity in various types of classes of peptidergic neurons.] Steroid Biocbeni Mol Biol 1991; 40; 93–103.
   Google Scholar